The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our center
Article in Frontiers in Immunology (May 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Preliminary results of a non-interventional single-center study evaluating the efficacy of long-term use of lanadelumab in routine clinical practice in the Russian Federation
Article in Russian Journal of Allergy (July 2023)